無管胰島素幫浦市場 - 按最終用途(家庭護理、醫院和診所)、行業分析報告、區域展望、應用潛力、競爭市場佔有率和預測,2023 - 2032 年
市場調查報告書
商品編碼
1399741

無管胰島素幫浦市場 - 按最終用途(家庭護理、醫院和診所)、行業分析報告、區域展望、應用潛力、競爭市場佔有率和預測,2023 - 2032 年

Tubeless Insulin Pump Market - By End-use (Homecare, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

由於人們對先進胰島素輸送方案和幫浦設計技術創新的認知不斷提高,2023 年至 2032 年全球無管胰島素幫浦市場CAGR將達到 19.2%。隨著個人和醫療保健提供者越來越意識到簡化和患者友好的解決方案,對無管胰島素幫浦的需求將會激增。技術進步提供了增強的功能和用戶便利性,進一步有助於市場擴張。不斷提高的意識和持續創新之間的協同作用將使無管胰島素幫浦成為不斷發展的糖尿病照護領域的關鍵組成部分,推動市場的上升軌跡。

公司正積極致力於為糖尿病患者創造解決方案。這種對創新的承諾透過擴大先進和患者友善選擇的範圍、促進可及性和改善整體糖尿病護理來增強無管胰島素幫浦市場。例如,2023 年,Insulet 正式推出 Omnipod 5 自動胰島素輸送系統,提供簡化的血糖管理,無需每日多次注射、試管或指尖採血。

無管胰島素幫浦產業根據最終用途和地區分為兩部分。

在先進糖尿病管理技術在醫療保健環境中日益一體化的推動下,到 2032 年,醫院和診所的最終用途細分市場將獲得顯著的市場佔有率。隨著醫院和診所優先考慮高效且患者友善的解決方案,對無管胰島素幫浦的需求將會激增。醫療保健提供者在促進和實施創新糖尿病護理解決方案方面發揮關鍵作用,這將使該細分市場成為擴大無管胰島素幫浦採用前景的主要貢獻者。

亞太地區無管胰島素幫浦市場將從 2023 年到 2032 年以顯著的CAGR成長,原因是該地區糖尿病患病率不斷上升、醫療基礎設施不斷發展以及對先進糖尿病管理技術的認知不斷提高。由於無管胰島素幫浦在胰島素輸送和連續血糖監測方面提供的便利性,對無管胰島素幫浦的需求特別高。隨著亞太地區的醫療保健系統優先考慮糖尿病護理,該地區將在塑造無管胰島素幫浦產業的發展軌跡和擴張方面發揮關鍵作用。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:無內胎胰島素幫浦產業見解

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 糖尿病盛行率上升
      • 無管胰島素幫浦的技術進步
      • 增加糖尿病照護支出
      • 傳統和侵入式胰島素幫浦造成的傷害
      • 透過促進性舉措
    • 產業陷阱與挑戰
      • 與無管胰島素幫浦相關的高長期成本
      • 嚴格的政府法規
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
    • 美國
    • 歐洲
  • 報銷場景
  • 技術景觀
  • 糖尿病的發生率和盛行率
  • 管道分析
  • 未來市場趨勢
  • 缺口分析
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 供應商矩陣分析
  • 戰略儀表板

第 5 章:無管胰島素幫浦市場規模與預測:依最終用途

  • 主要動向:依最終用途
  • 居家護理
  • 醫院和診所
  • 其他

第 6 章:無內胎胰島素幫浦市場規模與預測:按地區

  • 主要動向:按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 韓國

第 7 章:公司簡介

  • Insulet Corporation
  • Roche
  • Medtrum Technologies
  • Terumo Corporation
  • Mannkind Corporation
  • Terumo Corporation
Product Code: 2032

Global Tubeless Insulin Pump Market will register a 19.2% CAGR from 2023 to 2032, propelled by increasing awareness of advanced insulin delivery options and technological innovations in pump design. As individuals and healthcare providers become more conscious of streamlined and patient-friendly solutions, demand for tubeless insulin pumps will surge. Technological advancements, offering enhanced features and user convenience, further contribute to market expansion. The synergy between rising awareness and continuous innovation will position tubeless insulin pumps as pivotal components in the evolving landscape of diabetes care, propelling the market's upward trajectory.

Companies are actively working on creating solutions for individuals with diabetes. This commitment to innovation enhances the tubeless insulin pump market by expanding the range of advanced and patient-friendly options, promoting accessibility, and improving overall diabetes care. For instance, in 2023, Insulet officially introduced the Omnipod 5 automated insulin delivery system, offering simplified glucose management without the need for multiple daily injections, tubes, or fingersticks.

The tubeless insulin pump industry is bifurcated based on end-use and region.

The hospitals and clinics end-use segment will achieve remarkable market share by 2032, driven by the increasing integration of advanced diabetes management technologies in healthcare settings. As hospitals and clinics prioritize efficient and patient-friendly solutions, the demand for tubeless insulin pumps will surge. The pivotal role of healthcare providers in promoting and implementing innovative diabetes care solutions will position this segment as a major contributor to the expanding landscape of tubeless insulin pump adoption.

Asia-Pacific tubeless insulin pump market will grow at a noteworthy CAGR from 2023 to 2032, attributed to the region's increasing prevalence of diabetes, growing healthcare infrastructure, and rising awareness about advanced diabetes management technologies. The demand for tubeless insulin pumps is notably high, driven by the convenience they offer in insulin delivery and continuous glucose monitoring. As healthcare systems in Asia-Pacific prioritize diabetes care, the region will play a pivotal role in shaping the trajectory and expansion of the tubeless insulin pump industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Tubeless insulin pump industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Regional trends
  • 2.4 End-use trends

Chapter 3 Tubeless Insulin Pump Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of diabetes
      • 3.2.1.2 Technological advancements in tubeless insulin pump
      • 3.2.1.3 Increasing diabetes care expenditure
      • 3.2.1.4 Injuries caused by conventional & invasive insulin pumps
      • 3.2.1.5 Adoption of facilitative initiatives
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High long-term costs associated with tubeless insulin pump
      • 3.2.2.2 Stringent government regulations
  • 3.3 Growth potential analysis
    • 3.3.1 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 Incidence & prevalence of diabetes
  • 3.9 Pipeline analysis
  • 3.10 Future market trends
  • 3.11 Gap analysis
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Competitive positioning matrix
  • 4.5 Vendor matrix analysis, 2022
  • 4.6 Strategy dashboard, 2022

Chapter 5 Tubeless Insulin Pump Market Size and Forecast, By End-use (USD Million)

  • 5.1 Key trends, by end-use
  • 5.2 Home care
  • 5.3 Hospitals & clinics
  • 5.4 Others

Chapter 6 Tubeless Insulin Pump Market Size and Forecast, By Region (USD Million)

  • 6.1 Key trends, by region
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 UK
    • 6.3.3 France
    • 6.3.4 Spain
    • 6.3.5 Italy
  • 6.4 Asia Pacific
    • 6.4.1 Japan
    • 6.4.2 China
    • 6.4.3 Australia
    • 6.4.4 South Korea
  • 6.5 RoW

Chapter 7 Company Profiles

  • 7.1 Insulet Corporation
  • 7.2 Roche
  • 7.3 Medtrum Technologies
  • 7.4 Terumo Corporation
  • 7.5 Mannkind Corporation
  • 7.6 Terumo Corporation

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market share, by end-use (2022)
  • TABLE 3. Market share, by region (2022)
  • TABLE 4. Global tubeless insulin pump market size, 2018 - 2024 (USD Million)
  • TABLE 5. Global tubeless insulin pump market size, 2025 - 2032 (USD Million)
  • TABLE 6. Global tubeless insulin pump market, by region, 2018 - 2024 (USD Million)
  • TABLE 7. Global tubeless insulin pump market, by region, 2025 - 2032 (USD Million)
  • TABLE 8. Global tubeless insulin pump market, by end-use, 2018 - 2024 (USD Million)
  • TABLE 9. Global tubeless insulin pump market, by end-use, 2025 - 2032 (USD Million)
  • TABLE 10. Industry impact forces
  • TABLE 11. Home care market size, 2018 - 2024 (USD Million)
  • TABLE 12. Home care market size, 2025 - 2032 (USD Million)
  • TABLE 13. Hospitals & clinics care market size, 2018 - 2024 (USD Million)
  • TABLE 14. Hospitals & clinics care market size, 2025 - 2032 (USD Million)
  • TABLE 15. Others market size, 2018 - 2024 (USD Million)
  • TABLE 16. Others market size, 2025 - 2032 (USD Million)
  • TABLE 17. North America tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
  • TABLE 18. North America tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
  • TABLE 19. North America tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 20. North America tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 21. U.S. tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 22. U.S. tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 23. Canada tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 24. Canada tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 25. Europe tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
  • TABLE 26. Europe tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
  • TABLE 27. Europe tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 28. Europe tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 29. Germany tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 30. Germany tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 31. UK tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 32. UK tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 33. France tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 34. France tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 35. Spain tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 36. Spain tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 37. Italy tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 38. Italy tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 39. Asia Pacific tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
  • TABLE 40. Asia Pacific tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
  • TABLE 41. Asia Pacific tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 42. Asia Pacific tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 43. China tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 44. China tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 45. Japan tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 46. Japan tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 47. Australia tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 48. Australia tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 49. South Korea tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 50. South Korea tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 51. RoW tubeless insulin pump market size, by country, 2018 - 2024 (USD Million)
  • TABLE 52. RoW tubeless insulin pump market size, by country, 2025 - 2032 (USD Million)
  • TABLE 53. RoW tubeless insulin pump market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 54. RoW tubeless insulin pump market size, by end-use, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Tubeless insulin pump industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Industry ecosystem analysis
  • FIG. 9 Growth potential analysis, by end-use
  • FIG. 10 Porter's analysis
  • FIG. 11 PESTEL analysis
  • FIG. 12 Company matrix analysis, 2022
  • FIG. 13 Vendor matrix analysis
  • FIG. 14 Global company market share analysis, 2022
  • FIG. 15 Competitive positioning matrix
  • FIG. 16 Strategy dashboard, 2022